Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
TGF-alpha Antibody (MF9), DyLight 755, Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NBP234683IR
Description
TGF-alpha Monoclonal specifically detects TGF-alpha in Human, Mouse, Rat, Bovine samples. It is validated for Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin.Specifications
TGF-alpha | |
Monoclonal | |
DyLight 755 | |
protransforming growth factor alpha, TFGA, transforming growth factor, alpha, transforming growth factor-alpha | |
Mouse | |
6 kDa | |
0.1 mL | |
Angiogenesis, Cell Cycle and Replication, Signal Transduction | |
7039 | |
Human, Mouse, Rat, Bovine | |
Purified |
Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen) | |
MF9 | |
Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen | |
TGFA | |
A 17-amino acid synthetic peptide from the carboxyl-terminus of rat TGF-alpha (exact sequence is proprietary) (Uniprot: P01135) | |
Protein A or G purified | |
RUO | |
Primary | |
This antibody reacts with the C-terminus of TGF alpha and shows no cross-reaction with EGF and the neuropeptide synenkephalin. The staining with Ab-1 is completely blocked by the peptide used for raising this antibody. TGF (aa50) is a growth factor with 33% homology to EGF, binds to EGFR, activates tyrosine phosphorylation of the receptor, and stimulates cell proliferation. It plays a role in tumor initiation by inducing the reversible transformed phenotype. | |
Store at 4C in the dark. | |
IgG1 κ |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction